Search Results for: CLU

68 interactions involving CLU - clusterin found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel ADGRF4 adhesion G protein-coupled receptor F4
Novel CBR3 carbonyl reductase 3
  • Phase I - Functionalization of compounds
Novel DUSP13B dual specificity phosphatase 13B
Novel GEMIN7 gem nuclear organelle associated protein 7
  • snRNP Assembly
  • SARS-CoV-2 modulates host translation machinery
Novel KRT12 keratin 12
  • Keratinization
  • Formation of the cornified envelope
  • Griseofulvin
  • Anthralin
  • Meesmann corneal dystrophy
Novel NAT2 N-acetyltransferase 2
  • Acetylation
  • Paracetamol ADME
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1-dependent IKK and NF-kappa-B activation
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Gantenerumab
  • Aducanumab
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Lecanemab
  • Alzheimer's disease (AD)
BAG6 BAG cochaperone 6
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
BTG3 BTG anti-proliferation factor 3
C7 complement C7
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C8B complement C8 beta chain
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Zinc
  • Copper
  • Zinc acetate
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C9 complement C9
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Copper
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
CBY1 chibby 1, beta catenin antagonist
  • Deactivation of the beta-catenin transactivating complex
CD209 CD209 molecule
  • CD209 (DC-SIGN) signaling
  • Butyrophilin (BTN) family interactions
  • RSV-host interactions
CLUAP1 clusterin associated protein 1
  • Intraflagellar transport
  • Intraflagellar transport
CYP2E1 cytochrome P450 family 2 subfamily E member 1
  • Xenobiotics
  • CYP2E1 reactions
  • Biosynthesis of maresin-like SPMs
  • Aspirin ADME
  • Paracetamol ADME
  • Diacerein
DISC1 DISC1 scaffold protein
DLG4 discs large MAGUK scaffold protein 4
  • Signaling by ERBB4
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RHO GTPases activate CIT
  • RAF/MAP kinase cascade
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Guanidine
  • Guanosine-5'-Monophosphate
DSCAM DS cell adhesion molecule
  • DSCAM interactions
  • DSCAM interactions
DSCR9 Down syndrome critical region 9

Page 1 out of 4 pages